Experience

Korro Bio, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Senior manager FP&A

  • Oct 2023 - Present



Milestone Pharmaceuticals, Inc.

• Canada
• Biotechnology Research
• 1 - 100 Employee

• Senior Manager Finance

  • Mar 2022 - Sep 2023

  • Led the company’s annual financial planning process including budgeting and forecasting. • Collaborated regularly with functional leaders to ensure actual vs. projected budgets remain on track and unexpected contingencies are addressed. • Developed financial models such as Discounted Cash Flow (DCF) model, three-statement model, sensitivity analysis, scenario planning to perform analysis on potential financing opportunities and perform valuations.

• Senior Manager Financial Reporting

  • Jul 2021 - Mar 2022

  Biotech (NASDAQ - US GAAP) • Led SEC external reporting in compliance with all regulations, including 10-K, 10-Q and Proxy filings; supported the preparation of S-3 and S-8 registration statements, and earnings releases. • Led implementation of new ERP software “Microsoft Dynamics 365” with a focus on procure-to-pay and record-to-report processes.

• Manager Financial Reporting

  • Oct 2019 - Jun 2021

  Biotech (NASDAQ - US GAAP) Reviewed all contract research organization (CRO) contracts and coordinated with clinical and regulatory departments to standardize terms and develop accrual methodologies to ensure proper percentage of completion expense accrual. • Spearheaded financial reporting and prepared financial statements and management discussion and analysis (MD&A). • Conducted business analysis and piloted process improvement to assess and guide the implementation of internal… Show more Biotech (NASDAQ - US GAAP) Reviewed all contract research organization (CRO) contracts and coordinated with clinical and regulatory departments to standardize terms and develop accrual methodologies to ensure proper percentage of completion expense accrual. • Spearheaded financial reporting and prepared financial statements and management discussion and analysis (MD&A). • Conducted business analysis and piloted process improvement to assess and guide the implementation of internal controls. • Monitored and benchmarked financial disclosures for best practices with US GAAP, securities regulations, and industry peers; performed variance analysis of actuals versus forecasts. • Responsible for reviewing and signing off on all United States and Canadian corporate tax returns, including scientific research and experimental development (SR&ED). • Led implementation of Solium for share option awards, and employee stock purchase plans. • Prepared accounting memos, such as licensing revenue and warrant classification.



Acasti Pharma Inc.

• Canada
• Biotechnology Research
• 1 - 100 Employee

• Assistant Controller

  • Jan 2018 - Oct 2019

  Biotech (TSX & Nasdaq - IFRS) Biotech (TSX & Nasdaq - IFRS)



Deloitte

• Business Consulting and Services
• 700 & Above Employee

• Senior Auditor

  • Oct 2015 - Dec 2017

• Tax Analyst

  • Jan 2014 - Sep 2015